Development of a Decision Aid to Facilitate Ovarian Cancer Patient's Choices Regarding Biomarker CA125

CompletedOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

April 1, 2017

Primary Completion Date

June 30, 2022

Study Completion Date

December 31, 2022

Conditions
Ovarian Cancer
Trial Locations (1)

Unknown

Department of Oncology, Vejle Hospital, Vejle

All Listed Sponsors
collaborator

Danish Cancer Society

OTHER

collaborator

Design School Kolding

OTHER

lead

Vejle Hospital

OTHER

NCT03004391 - Development of a Decision Aid to Facilitate Ovarian Cancer Patient's Choices Regarding Biomarker CA125 | Biotech Hunter | Biotech Hunter